Diabetes-related factors and abdominal aortic aneurysm events: the Atherosclerotic Risk in Communities Study

Annals of Epidemiology

Volumn 28, Issue 2, 2018, Pages 102-106.e1

  Kubota, Yasuhiko ^a   Folsom, Aaron R ^a   Pankow, James S ^a   Wagenknecht, Lynne E ^b   Tang, Weihong ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Abdominal aortic aneurysm; Diabetes; Leptin; Metabolic syndrome

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL AORTIC ANEURYSM; ADULT; ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; FASTING; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ABDOMINAL OBESITY; BLOOD; METABOLISM;

AORTIC ANEURYSM, ABDOMINAL; BLOOD GLUCOSE; CHOLESTEROL, HDL; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME; MIDDLE AGED; OBESITY, ABDOMINAL;

EID: 85038873511     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2017.12.003     Document Type: Article

References (25)

1. U.S. Preventive Services Task Force. Screening for abdominal aortic aneurysm: recommendation statement. Ann Intern Med 142 (2005), 198–202.
2. Golledge, J., Tsao, P.S., Dalman, R.L., Norman, P.E., Circulating markers of abdominal aortic aneurysm presence and progression. Circulation 118 (2008), 2382–2392.
3. Lederle, F.A., Johnson, G.R., Wilson, S.E., Chute, E.P., Hye, R.J., Makaroun, M.S., et al. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med 160 (2000), 1425–1430.
4. Lederle, F.A., Larson, J.C., Margolis, K.L., Allison, M.A., Freiberg, M.S., Cochrane, B.B., et al. Abdominal aortic aneurysm events in the women's health initiative: cohort study. BMJ, 337, 2008, a1724.
5. Bhak, R.H., Wininger, M., Johnson, G.R., Lederle, F.A., Messina, L.M., Ballard, D.J., et al. Factors associated with small abdominal aortic aneurysm expansion rate. JAMA Surg 150 (2015), 44–50.
6. Sidloff, D., Stather, P., Dattani, N., Bown, M., Thompson, J., Sayers, R., et al. Aneurysm global epidemiology study: public health measures can further reduce abdominal aortic aneurysm mortality. Circulation 129 (2014), 747–753.
7. Takagi, H., Umemoto, T., A meta-analysis of the association of obesity with abdominal aortic aneurysm presence. Int Angiol 34 (2015), 383–391.
8. Tang, W., Yao, L., Roetker, N.S., Alonso, A., Lutsey, P.L., Steenson, C.C., et al. Lifetime risk and risk factors for abdominal aortic aneurysm in a 24-year prospective study: the ARIC study (Atherosclerosis Risk in Communities). Arterioscler Thromb Vasc Biol 36 (2016), 2468–2477.
9. Schmidt, M.I., Duncan, B.B., Vigo, A., Pankow, J.S., Couper, D., Ballantyne, C.M., et al. Leptin and incident type 2 diabetes: risk or protection?. Diabetologia 49 (2006), 2086–2096.
10. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. The ARIC Investigators. Am J Epidemiol 129 (1989), 687–702.
11. Kubota, Y., London, S.J., Cushman, M., Chamberlain, A.M., Rosamond, W.D., Heckbert, S.R., et al. Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study. J Thromb Haemost 14 (2016), 2394–2401.
12. Kubota, Y., Heiss, G., MacLehose, R.F., Roetker, N.S., Folsom, A.R., Educational attainment and lifetime risk of cardiovascular disease: the Atherosclerosis Risk in Communities Study. JAMA Intern Med 77:8 (2017), 1165–1172.
13. Dearborn, J.L., Schneider, A.L., Sharrett, A.R., Mosley, T.H., Bezerra, D.C., Knopman, D.S., et al. Obesity, insulin resistance, and incident small vessel disease on magnetic resonance imaging: Atherosclerosis Risk in Communities Study. Stroke 46 (2015), 3131–3136.
14. Salomaa, V., Riley, W., Kark, J.D., Nardo, C., Folsom, A.R., Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 91 (1995), 1432–1443.
15. Folsom, A.R., Nieto, F.J., McGovern, P.G., Tsai, M.Y., Malinow, M.R., Eckfeldt, J.H., et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 98 (1998), 204–210.
16. Folsom, A.R., Yao, L., Alonso, A., Lutsey, P.L., Missov, E., Lederle, F.A., et al. Circulating biomarkers and abdominal aortic aneurysm incidence: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 132 (2015), 578–585.
17. Enriori, P.J., Evans, A.E., Sinnayah, P., Cowley, M.A., Leptin resistance and obesity. Obesity (Silver Spring) 14:Suppl 5 (2006), 254S–258S.
18. McNeely, M.J., Boyko, E.J., Weigle, D.S., Shofer, J.B., Chessler, S.D., Leonnetti, D.L., et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care 22 (1999), 65–70.
19. Boyko, E.J., de Courten, M., Zimmet, P.Z., Chitson, P., Tuomilehto, J., Alberti, K.G., Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius. Diabetes Care 23 (2000), 1242–1248.
20. Franks, P.W., Brage, S., Luan, J., Ekelund, U., Rahman, M., Farooqi, I.S., et al. Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obes Res 13 (2005), 1476–1484.
21. De Rango, P., Farchioni, L., Fiorucci, B., Lenti, M., Diabetes and abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 47 (2014), 243–261.
22. Festa, A., D'Agostino, R. Jr., Mykkänen, L., Tracy, R.P., Zaccaro, D.J., Hales, C.N., et al. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. the Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler Thromb Vasc Biol 19 (1999), 562–568.
23. Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O'Reilly, D.S., Haffner, S.M., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003), 414–419.
24. Wang, J., Ruotsalainen, S., Moilanen, L., Lepistö, P., Laakso, M., Kuusisto, J., The metabolic syndrome predicts incident stroke: a 14-year follow-up study in elderly people in Finland. Stroke 39 (2008), 1078–1083.
25. Conen, D., Rexrode, K.M., Creager, M.A., Ridker, P.M., Pradhan, A.D., Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women: a prospective study. Circulation 120 (2009), 1041–1047.